Enhertu® Approved in the U.S. for Two New Indications for Patients with HER2 Positive Early Breast Cancer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. INTC
2. SPCX
3. DSX
4. GNK
5. SAN
6. TTEC
7. SNY
8. DAL
9. AWK
10. MDA

Go back to Enhertu® Approved in the U.S. for Two New Indications for Patients with HER2 Positive Early Breast Cancer
ASTRAZENECA PLC (NASDAQ: AZN) Delayed: 92.77 --0 (-0%)
Previous Close $92.77    52 Week High $35.04 
Open $92.77    52 Week Low $26.97 
Day High $92.77    P/E N/A 
Day Low $92.77    EPS $0.00 
Volume 1,667,048       

ASTRAZENECA PLC (NASDAQ: AZN) Delayed: 92.77 --0 (-0%)
Previous Close $92.77    52 Week High $35.04 
Open $92.77    52 Week Low $26.97 
Day High $92.77    P/E N/A 
Day Low $92.77    EPS $0.00 
Volume 1,667,048       

Daiichi Sankyo Co Limited Sponsored ADR (AMEX: DSNKY) Delayed: 16.92 +0.68 (4.19%)
Previous Close $16.24    52 Week High $26.24 
Open $16.97    52 Week Low $18.86 
Day High $16.97    P/E N/A 
Day Low $16.83    EPS $0.00 
Volume 384,726